Trials / Completed
CompletedNCT03557398
Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women
Prospective Clinical Study to Assess the Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Fidia Farmaceutici s.p.a. · Industry
- Sex
- Female
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy and safety of hyaluronic acid derivative based vaginal pessaries for the treatment of symptoms of vulvo-vaginal atrophy in post-menopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hydeal-D vaginal pessaries | One vaginal application of Hydeal-D vaginal pessaries every 3 days to a total of 12 consecutive weeks. |
Timeline
- Start date
- 2017-11-29
- Primary completion
- 2018-05-29
- Completion
- 2018-05-29
- First posted
- 2018-06-15
- Last updated
- 2018-06-15
Locations
2 sites across 1 country: Slovakia
Source: ClinicalTrials.gov record NCT03557398. Inclusion in this directory is not an endorsement.